NovoLog and Orphenadrine Extended-Release Tablets
Determining the interaction of NovoLog and Orphenadrine Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: NovoLog, NovoLog FlexPen, NovoLog PenFill, Fiasp, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Novolog
Generic Name: orphenadrine
Brand name: Norflex, Banflex, Orphenate, Flexoject, Flexon, Mio-Rel, Myolin, Orfro, Norflex Injectable, Antiflex
Synonyms: Orphenadrine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovoLog-Orphenadrine Injection
- NovoLog-Orphenadrine w/A.C.
- NovoLog-Orphenadrine, aspirin, and caffeine
- NovoLog-Orphenate
- NovoLog-Orphengesic
- NovoLog-Orphengesic Forte
- Orphenadrine Extended-Release Tablets-NovoLog FlexPen
- Orphenadrine Extended-Release Tablets-Novolog Injection
- Orphenadrine Extended-Release Tablets-NovoLog Mix 70/30
- Orphenadrine Extended-Release Tablets-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- Orphenadrine Extended-Release Tablets-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- Orphenadrine Extended-Release Tablets-NovoLog Mix 70/30 FlexPen